• individual investors
  • institutions & advisors
  • My Value Line
  • Sign In
  • Subscribe
Value Line
smaller default larger
  • Research Hub
    • Stocks

    • Overview
    • Dow 30 Coverage
    • Investment Survey
    • Investment Survey Plus
    • Small & Midcap Survey
    • Special Situations
    • Select
    • Dividend Select
    • Value Line 600
    • Analyzer
    • Funds

    • Overview
    • Fund Advisor
    • Fund Advisor Plus
    • Fund Survey for Windows
    • Options

    • Overview
    • Options Survey
    • Convertibles

    • Overview
    • Convertibles Survey
    • ETF

    • ETF Professional
    • Tools

    • Overview
    • Screener
    • Model Portfolio
    • Portfolio Tracker
    • Glossary
  • Markets
    • Overview

    • Daily Updates

    • Economic Calendar

    • Commentary

  • Products
    • Overview

    • Stocks

    • Funds

    • Options

    • Convertibles

    • ETFs

    • Data Licensing

    • Research Center

  • Investment Education
    • Overview

    • Getting Started

    • How To Use

    • Sample Reports

    • Guides

    • Articles

    • FAQs

    • Glossary

    • Free Reports

    • Ranks

    Research

  • My Value Line
  • Market Review
  • Symbol Lookup

    Products

  • Research Center
  • Investment Survey
  • Investment Survey Plus
  • Value Line 600
  • Small & Midcap Survey
  • Select
  • Dividend Select
  • Special Situations
  • Analyzer
  • Fund Advisor
  • Fund Advisor Plus
  • Fund Survey for Windows
  • Options Survey
  • Convertibles Survey
  • ETF Professional
  • Free Reports

    Need help?

  • View Our FAQs
  • Retrieve Password
  • Contact Us
  • View Our Guides
  • Glossary

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2013-05-24)Premium Content
  • Quotes
  • News
  • Option Data
  • Graphs
  • Time/Sales

Nuvasive Inc (NUVA)

2013-05-21@10:08:02 ET
Potential Nuvasive (NUVA) Trade Targets 21.20% Return (FBM)

2013-05-21@05:09:45 ET
Form 144: Filing to Sell 7500 Shares of NuVasive Inc (NUVA) (VKR)

2013-05-20@11:26:07 ET
NuVasive Earnings Hindsight: Up 11.1% in Last 20 Days (NUVA) (PSM)

2013-05-20@05:26:52 ET
Australia: NuVasive Receives Patent for 'System and methods for determining nerve proximity, direction, and pathology during surgery' (ABW)

2013-05-18@09:45:06 ET
NuVasive Earnings In Retrospect: Up 11.1% in the Last 18 Days (NUVA) (F73)

2013-05-17@13:09:12 ET
NuVasive Shares Climbing Higher, Up 1.7% (F77)

2013-05-17@04:48:45 ET
Form 144: Filing to Sell 12500 Shares of NuVasive Inc (NUVA) (VKR)

2013-05-15@09:43:18 ET
Nuvasive (NUVA) Could Break Through $22.86 Resistance Level (FBM)

2013-05-15@07:20:07 ET
Form 4: Update Filing for NuVasive Inc (NUVA) (VKR)

2013-05-13@13:17:37 ET
NuVasive Makes a Move: Up 1.6% (F77)

2013-05-13@10:22:38 ET
NuVasive reports higher Q1 net income, provides outlook for 2013 (DTM)

2013-05-11@07:54:22 ET
Form 4: Update Filing for NuVasive Inc (NUVA) (VKR)



Value Line  
  • About Value Line
  • Terms & Conditions
  • Privacy
  • Copyright
  • Trademark
  • Quick Facts
valueline.com  
  • Contact Value Line
  • Feedback
  • Site Map
  • eNewsletters
  • Subscribe
valuelinepro.com  
  • About Value Line Institutional Services
  • Contact Value Line Institutional Services
Connect with us Twitter Facebook Linked in google+ RSS
© 2013 VALUE LINE, INC. All RIGHTS RESERVED